In line with this premise, our results show that enhanced MTFP1 protein expression upon p53 loss heightens Drp1 S616 phosphorylation and mitochondrial fission to enable ERK1/2 activation, resulting in the EMT-associated morphologic switch, elevated MMP9 expression, and cancer cell dissemination. The gene discussed is MAPK3; the disease is cancer.